BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial
Abstract Acellular pertussis (aP) booster vaccines are central to pertussis immunization programs, although their effectiveness varies. The Bacille Calmette-Guérin (BCG) vaccine is a prototype inducer of trained immunity, which enhances immune responses to subsequent infections or vaccinations. Whil...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-022-00438-4 |